In the univariate analysis, the results showed that age, gender, smoking history, tumor length, T stage, lymph node metastasis, TNM stage and SUSD2 expression were associated with the OS of LUAD patients (all P < 0.05) (Table 3). This evidence concerns the gene SUSD2 and metastatic malignant neoplasm in the lymph nodes.